Gene · 2946
Papers3,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicles as potential tools for regenerative therapy. | Mol Cell Oncol | 2020 | 33235912 | PubTator, text mining | PubMed |
| The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies. | Antioxidants (Basel) | 2020 | 33228209 | PubTator, text mining | PubMed |
| Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19. | Evid Based Complement Alternat Med | 2020 | 33204291 | PubTator, text mining | PubMed |
| Glutathione S-transferases gene polymorphism influence on the age of diabetes type 2 onset. | BMJ Open Diabetes Res Care | 2020 | 33203728 | PubTator, text mining | PubMed |
| Role of Adiponectin and Tumor Necrosis Factor-Alpha in the Pathogenesis and Evolution of Type 1 Diabetes Mellitus in Children and Adolescents. | Diagnostics (Basel) | 2020 | 33202729 | PubTator, text mining | PubMed |
| Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. | Comput Struct Biotechnol J | 2020 | 33200026 | PubTator, text mining | PubMed |
| Metastatic Breast Cancer and Pre-Diagnostic Blood Gene Expression Profiles-The Norwegian Women and Cancer (NOWAC) Post-Genome Cohort. | Front Oncol | 2020 | 33178605 | PubTator, text mining | PubMed |
| A Study on the Mechanism of Milkvetch Root in the Treatment of Diabetic Nephropathy Based on Network Pharmacology. | Evid Based Complement Alternat Med | 2020 | 33178322 | PubTator, text mining | PubMed |
| Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. | Cells | 2020 | 33167477 | PubTator, text mining | PubMed |
| A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients. | Biomed Res Int | 2020 | 33150179 | PubTator, text mining | PubMed |
| Omics in Myopia. | J Clin Med | 2020 | 33126435 | PubTator, text mining | PubMed |
| GSTM3 Function and Polymorphism in Cancer: Emerging but Promising. | Cancer Manag Res | 2020 | 33116892 | PubTator, text mining | PubMed |
| Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review. | Pharmgenomics Pers Med | 2020 | 33116759 | PubTator, text mining | PubMed |
| Tandem Mass Tag-Based Serum Proteome Profiling for Biomarker Discovery in Young Duchenne Muscular Dystrophy Boys. | ACS Omega | 2020 | 33110978 | PubTator, text mining | PubMed |
| Association of Genetic Polymorphisms in GSTP1, GSTM1, and GSTT1 Genes with Vesicoureteral Reflux Susceptibility in the Children of Southeast Iran. | Iran J Public Health | 2020 | 33083304 | PubTator, text mining | PubMed |
| Advances in Prognostic Methylation Biomarkers for Prostate Cancer. | Cancers (Basel) | 2020 | 33076494 | PubTator, text mining | PubMed |
| Circular RNAs as New Regulators in Gastric Cancer: Diagnosis and Cancer Therapy. | Front Oncol | 2020 | 33072546 | PubTator, text mining | PubMed |
| Edentulousness in severely mentally ill patients: A pilot study of sex-specific patterns for risk factors including the glutathione S-transferase M1 gene. | Schizophr Res | 2020 | 33067056 | PubTator, text mining | PubMed |
| microRNAs involved in the control of toxicity on locomotion behavior induced by simulated microgravity stress in Caenorhabditis elegans. | Sci Rep | 2020 | 33060753 | PubTator, text mining | PubMed |
| Beetroot, a Remarkable Vegetable: Its Nitrate and Phytochemical Contents Can be Adjusted in Novel Formulations to Benefit Health and Support Cardiovascular Disease Therapies. | Antioxidants (Basel) | 2020 | 33049969 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2946/papers?page=28